DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced today that David Bupp, its President and CEO and certain members of his family last week purchased a $1 million convertible note and warrants of the Company.
